The Role of Individually Selected Diets in Obese Women with PCOS-A Review
- PMID: 36364814
- PMCID: PMC9656326
- DOI: 10.3390/nu14214555
The Role of Individually Selected Diets in Obese Women with PCOS-A Review
Abstract
Polycystic ovarian syndrome (PCOS) is one of the most common heterogeneous endocrine and metabolic disorders in premenopausal women. It is a complex multifactorial disorder with strong epigenetic and environmental influences, including factors related to eating habits and lifestyle. There is a close relationship between obesity and PCOS. Weight gain and obesity are often clinical symptoms manifested by biochemical markers. Moreover, abdominal obesity in women with PCOS is involved in the development of inflammatory changes. A significant share of balanced therapies correcting the lifestyle of patients is suggested, e.g., with the implementation of appropriate diets to minimize exposure to inflammatory factors and prevent abnormal immune system stimulation. In the case of obese patients with PCOS, planning a diet program and supporting the motivation to change eating habits play an important role to lose weight and lower BMI. Probiotics/synbiotic supplementation may enhance weight loss during the diet program and additionally positively affect metabolic and inflammatory factors by improving the intestinal microbiome.
Keywords: diet; obesity/overweight; polycystic ovary syndrome; probiotics/synbiotic.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.Hum Reprod. 2014 Jul;29(7):1526-35. doi: 10.1093/humrep/deu114. Epub 2014 May 19. Hum Reprod. 2014. PMID: 24842895
-
Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility.Endocrine. 2013 Dec;44(3):583-90. doi: 10.1007/s12020-013-9971-5. Epub 2013 Apr 27. Endocrine. 2013. PMID: 23625194 Review.
-
Dietary intake, eating behaviors, and quality of life in women with polycystic ovary syndrome who are trying to conceive.Hum Fertil (Camb). 2015 Mar;18(1):16-21. doi: 10.3109/14647273.2014.922704. Epub 2014 Jun 12. Hum Fertil (Camb). 2015. PMID: 24921163 Clinical Trial.
-
The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.Clin Endocrinol (Oxf). 2014 Mar;80(3):432-8. doi: 10.1111/cen.12305. Epub 2013 Aug 28. Clin Endocrinol (Oxf). 2014. PMID: 23909452 Clinical Trial.
-
The role of obesity in the development of polycystic ovary syndrome.Curr Pharm Des. 2012;18(17):2482-91. doi: 10.2174/13816128112092482. Curr Pharm Des. 2012. PMID: 22376149 Review.
Cited by
-
The Impact of Polycystic Ovary Syndrome on Gestational Diabetes Mellitus, Disease Knowledge, and Health Behaviors.Healthcare (Basel). 2025 Mar 24;13(7):717. doi: 10.3390/healthcare13070717. Healthcare (Basel). 2025. PMID: 40218015 Free PMC article.
-
BMI and Polycystic Ovary Syndrome: Demographic Trends in Weight and Health.Cureus. 2024 Mar 3;16(3):e55439. doi: 10.7759/cureus.55439. eCollection 2024 Mar. Cureus. 2024. PMID: 38567220 Free PMC article.
-
Superior metabolic improvement of polycystic ovary syndrome traits after GLP1-based multi-agonist therapy.Nat Commun. 2024 Oct 1;15(1):8498. doi: 10.1038/s41467-024-52898-y. Nat Commun. 2024. PMID: 39353946 Free PMC article.
-
Inflammation mediates the effect of adiposity and lipid metabolism indicators on the embryogenesis of PCOS women undergoing in vitro fertilization/intracytoplasmic sperm injection.Front Endocrinol (Lausanne). 2023 Jul 25;14:1198602. doi: 10.3389/fendo.2023.1198602. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37560312 Free PMC article.
-
Correlation between Selected Clinical Symptoms and Severity of Aggression, Impulsiveness and Their Selected Behavioral Manifestations in Patients with Polycystic Ovary Syndrome Phenotype A.Metabolites. 2023 May 9;13(5):646. doi: 10.3390/metabo13050646. Metabolites. 2023. PMID: 37233687 Free PMC article.
References
-
- Ng N.Y.H., Jiang G., Cheung L.P., Zhang Y., Tam C.H.T., Luk A.O.Y., Quan J., Lau E.S.H., Yau T.T.L., Chan M.H.M. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study. PLoS Med. 2019;16:e1002953. doi: 10.1371/journal.pmed.1002953. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical